FULC
Price:
$3.25
Market Cap:
$175.30M
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmon...[Read more]
Industry
Biotechnology
IPO Date
2019-07-18
Stock Exchange
NASDAQ
Ticker
FULC
According to Fulcrum Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 111.82M. This represents a change of -68.61% compared to the average of 356.23M of the last 4 quarters.
The mean historical Enterprise Value of Fulcrum Therapeutics, Inc. over the last ten years is 280.01M. The current 111.82M Enterprise Value has changed 3.89% with respect to the historical average. Over the past ten years (40 quarters), FULC's Enterprise Value was at its highest in in the September 2021 quarter at 967.18M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
280.01M
Median
239.86M
Minimum
87.14M
Maximum
590.12M
Discovering the peaks and valleys of Fulcrum Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 175.25%
Maximum Annual Enterprise Value = 590.12M
Minimum Annual Increase = -48.17%
Minimum Annual Enterprise Value = 87.14M
Year | Enterprise Value | Change |
---|---|---|
2023 | 399.10M | 30.48% |
2022 | 305.86M | -48.17% |
2021 | 590.12M | 146.03% |
2020 | 239.86M | 175.25% |
2019 | 87.14M | -44.12% |
2018 | 155.94M | -14.33% |
The current Enterprise Value of Fulcrum Therapeutics, Inc. (FULC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
431.69M
5-year avg
324.42M
10-year avg
280.01M
Fulcrum Therapeutics, Inc.’s Enterprise Value is greater than RAPT Therapeutics, Inc. (4.97M), less than Mirum Pharmaceuticals, Inc. (2.24B), greater than BeyondSpring Inc. (65.41M), less than Stoke Therapeutics, Inc. (457.69M), less than Phathom Pharmaceuticals, Inc. (480.38M),
Company | Enterprise Value | Market cap |
---|---|---|
4.97M | $37.75M | |
2.24B | $2.15B | |
65.41M | $70.12M | |
457.69M | $605.41M | |
480.38M | $638.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fulcrum Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fulcrum Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Fulcrum Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Fulcrum Therapeutics, Inc. (FULC)?
What is the 3-year average Enterprise Value for Fulcrum Therapeutics, Inc. (FULC)?
What is the 5-year average Enterprise Value for Fulcrum Therapeutics, Inc. (FULC)?
How does the current Enterprise Value for Fulcrum Therapeutics, Inc. (FULC) compare to its historical average?